CNS Summit: Medable Defines New Era of Clinical Trials

BOCA RATON, FLORIDA—Medable CEO Dr. Michelle Longmire will be on a CNS Summit 2018 panel today focusing on virtual clinical trials.  Medable is the first and only unified platform as a service for clinical trials. The platform enables seamless activity and actions for all stakeholders in the clinical trial ecosystem. To date, Medable has over 500,000 patients on the platform through partnerships and customers across nearly 6,000 clinical trials.  Every day, people use Medable mobile applications and connected devices to navigate clinical trials and complex healthcare protocols.   The panel will be held at 1:45-3:15pm ET.

Longmire will talk about how the Medable platform fits into the new era of clinical trials, and specifically how the company is taking aim at bottlenecks in research participation.  Every day, each of us is generating a massive amount of data: email, texts, photos, purchasing, and beyond. In addition, health is becoming connected through ubiquitous sensing. How can we leverage this new era of personal data generation?  Through secure and HIPAA compliant cloud-based and mobile app solutions, Medable offers a unified end-to-end platform to help clients navigate the complexities of running clinical trials, implementing research, and identifying key data for personalized medicine.  In addition to other honors, Longmire was recently named by FastCompany Magazine as one of the most creative people in business, and the company was just named the winner of the Dpharm Idol competition.